Cargando…

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety disorder (GAD). Monitoring of blood levels (BLs) is strongly indicated due to ESC’s high interindividual pharmacokinetic variability. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hart, X. M., Heesen, S., Schmitz, C. N., Dörfler, S., Wedekind, D., Gründer, G., Hiemke, C., Havemann-Reinecke, U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958172/ https://www.ncbi.nlm.nih.gov/pubmed/36207527 http://dx.doi.org/10.1007/s00406-022-01491-9

Ejemplares similares

Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study
por: Hart, Xenia M., et al.
Publicado: (2023)

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
por: Eichentopf, Luzie, et al.
Publicado: (2022)

Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
por: Vierke, Christopher, et al.
Publicado: (2020)

Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatients
por: Wedekind, Dirk, et al.
Publicado: (2013)

S100B and homocysteine in the acute alcohol withdrawal syndrome
por: Wedekind, Dirk, et al.
Publicado: (2010)

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
por: Dell’Osso, Bernardo, et al.
Publicado: (2013)

Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial
por: Choi, Kwan-Woo, et al.
Publicado: (2012)

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors
por: Funk, Cleo S. M., et al.
Publicado: (2022)

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
por: Hart, Xenia M., et al.
Publicado: (2022)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Behavioral restriction, lorazepam, and escitalopram uniquely influence the expression of naturalistic stereotypy in deer mice: perspectives on anxiety- and compulsive-like behavior
por: Burke, Johann T., et al.
Publicado: (2022)

Association between the high-dose use of benzodiazepines and rehospitalization in patients with schizophrenia: a 2-year naturalistic study
por: Takita, Yukika, et al.
Publicado: (2016)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke
por: Kim, Jarim, et al.
Publicado: (2018)

Catatonia in mixed alcohol and benzodiazepine withdrawal
por: Basu, Aniruddha, et al.
Publicado: (2014)

Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
por: Hart, Xenia M., et al.
Publicado: (2021)

Polysubstance Abuse: Alcohol, Opioids and Benzodiazepines Require Coordinated Engagement by Society, Patients, and Physicians
por: Ogbu, Uzor C., et al.
Publicado: (2015)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

PS91. The effects of fluvoxamine on the steady-state plasma concentrations of escitalopram and desmethylescitalopram in depressed Japanese patients.
por: Kubo, Kazutoshi, et al.
Publicado: (2016)

Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal
por: Lebin, Jacob A., et al.
Publicado: (2021)

Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
por: Muhonen, Leea H, et al.
Publicado: (2008)

Benzodiazepine maintenance for alcohol dependence: A case series
por: Kattimani, Shivanand, et al.
Publicado: (2017)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Benzodiazepine use, misuse, and abuse: A review
por: Schmitz, Allison
Publicado: (2016)

PT705. Therapeutic Drug Monitoring (TDM) in maternal serum, amniotic fluid and umbilical cord blood during pregnancy and delivery
por: Paulzen, Michael, et al.
Publicado: (2016)

Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
por: Chavda, Nilesh, et al.
Publicado: (2011)

Effect of Escitalopram on White Blood Cells in Patients With Major Depression
por: Canan, Fatih, et al.
Publicado: (2009)

Escitalopram co-prescription in anastrozole-treated breast cancer patients
por: Ozyurt, Hazan, et al.
Publicado: (2022)

Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression
por: O'Brien, Fionn E., et al.
Publicado: (2015)

Advantages and Limitations of Naturalistic Study Designs and Their Implementation in Alcohol Hangover Research
por: Verster, Joris C., et al.
Publicado: (2019)

Hypnic jerks possibly induced by escitalopram
por: Sathe, Harshal, et al.
Publicado: (2015)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

Association of Alcohol Consumption with Perception of Attractiveness in a Naturalistic Environment
por: Maynard, Olivia M., et al.
Publicado: (2016)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2016)

Perospirone augmentation of escitalopram in the treatment of an adolescent sophophobia (fear of learning) patient
por: Miyazaki, Kensuke
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_anv58o074l0e3spqjsef27rj7l